BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 16, 2014
View Archived Issues
Results of a first-in-human phase I/II study with SA4Ag vaccine
Read More
Clinical trial tests the efficacy, safety and tolerability of selisistat
Read More
LassBio-1386 investigated for the treatment of PAH in a rat model
Read More
New ROR-gamma receptor modulators disclosed by Bristol-Myers Squibb and Exelixis
Read More
Ligand signs agreement with Omthera Pharmaceuticals for dyslipidemia-related diseases
Read More
TNF-alpha in saliva tested as a potential biomarker for carotid atherosclerosis
Read More
PATH to initiate phase III trial of oral rotavirus vaccine
Read More
INK-128 to be evaluated in glioblastoma patients undergoing surgery
Read More
Astex Pharmaceuticals joins Cancer Research UK's ECMC Combinations Alliance
Read More
Heron Therapeutics selects HTX-011 as lead candidate for post-surgical pain program
Read More
New IDH1/IDH2 inhibitors divulged by Agios Pharmaceuticals
Read More
Novel agents for HCV infection presented by Bristol-Myers Squibb
Read More
Researchers at Roche synthesize new mGlu5 receptor modulators
Read More
Retrophin provides access to RE-024 in pantothenate kinase-associated neurodegeneration
Read More
Portola Pharmaceuticals starts enrollment in phase III study of andexanet alfa and Xarelto
Read More
Senhwa Biosciences to begin phase I/II study of CX-4945 in cholangiocarcinoma
Read More
Phase II TT-401 trial begins in type 2 diabetes
Read More
MRC Technology and Daiichi Sankyo to identify novel targets for drug discovery
Read More
Ardelyx receives milestone payment for initiation of phase tenapanor trial
Read More
ZN-2007 as a novel HCV NS3 inhibitor with excellent in vivo activity and safety
Read More
Diffusion's phase I/II study of TSC for GBM reaches 1-year interim endpoint
Read More
Transgene's TG-6002 shows activity in mouse cancer models
Read More
Apricus to initiate phase IIa study of alprostadil cream in Raynaud's phenomenon
Read More
Nymox reports positive results from phase II trial of NX-1207 in prostate cancer
Read More